Friday, February 1, 2013

NYT > Health: Europe Says Johnson & Johnson Paid to Delay Generic Fentanyl

Europe Says Johnson & Johnson Paid to Delay Generic Fentanyl

Johnson & Johnson and Novartis were accused of colluding to delay the availability of a less expensive version of a pain medication for cancer patient...

Source: http://www.nytimes.com/2013/02/01/business/global/eu-says-drug-makers-paid-to-delay-generic-version.html?partner=rss&emc=rss


No comments:

Post a Comment

Subscribe Now: Feed Icon